Hamilton Wealth’s IGM Biosciences IGMS Stock Holding History

Hamilton Wealth’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,000	Closed	-$61.1K	–	118
2024 Q4	$61.1K	Buy	+10,000	New	+$119K	0.01%	96

Other funds holding IGMS

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Hamilton Wealth's IGMS Position: Q1 2025 in Review

Hamilton Wealth sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 10,000 shares — an estimated $61.1K sold.

Hamilton Wealth first reported a position in IGMS in Q4 2024 and held it in 1 quarter. The position peaked at $61.1K in Q4 2024. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

Hamilton Wealth reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
Hamilton Wealth sold 10,000 IGM Biosciences shares in Q1 2025, an estimated $61.1K.
Hamilton Wealth first reported a position in IGM Biosciences in Q4 2024 and held it in 1 quarter.
Hamilton Wealth's IGM Biosciences position peaked at $61.1K in Q4 2024.
79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on Hamilton Wealth's 13F filing for Q1 2025, filed 14 Nov 2025.